Tag: PFE

Finance

Healthcare Active Movers: Pfizer Inc. (NYSE:PFE), Gilead Sciences, Inc. (NASDAQ:GILD), PTC Therapeutics, Inc. (NASDAQ:PTCT), Inovio Pharmaceuticals Inc (NYSEMKT:INO)

US drugmaker Pfizer Inc (NYSE:PFE) on Monday abandoned its pursuit to buy AstraZeneca PLC, saying it does not plan to make an offer for the British drugmaker following the rejection of its final proposal last week. Pfizer Inc. (NYSE:PFE) stock performance was -0.57% in last session and finished the day at $29.49. Traded volume was 18.93million shares in the last session and the average volume … Continue reading Healthcare Active Movers: Pfizer Inc. (NYSE:PFE), Gilead Sciences, Inc. (NASDAQ:GILD), PTC Therapeutics, Inc. (NASDAQ:PTCT), Inovio Pharmaceuticals Inc (NYSEMKT:INO)

Jayne Crisman
CSCO NASDAQ CSCO Cisco Systems
Finance, Software

Hot Movers: Cisco Systems (NASDAQ:CSCO), Pfizer Inc. (NYSE:PFE), World Wrestling Entertainment (NYSE:WWE), J.C. Penney Company (NYSE:JCP), Verizon Communications Inc. (NYSE:VZ)

Cisco Systems, Inc. (NASDAQ:CSCO) recently named Marco Inc. its 2013 Central Area Small to Medium Business Partner of the Year for leadership in implementing unified communications and cloud networking systems among other Cisco Systems, Inc. (NASDAQ:CSCO) technologies. Cisco Systems, Inc. (NASDAQ:CSCO) stock performance was 0.79% in last session and finished the day at $24.37. Traded volume was 40.48million shares in the last session and the … Continue reading Hot Movers: Cisco Systems (NASDAQ:CSCO), Pfizer Inc. (NYSE:PFE), World Wrestling Entertainment (NYSE:WWE), J.C. Penney Company (NYSE:JCP), Verizon Communications Inc. (NYSE:VZ)

Mark DeFrance
Finance

Healthcare Active Stocks: Pfizer Inc. (NYSE:PFE), Merck & Co., Inc. (NYSE:MRK), Gilead Sciences (NASDAQ:GILD), MannKind Corporation (NASDAQ:MNKD)

Pfizer Inc. (NYSE:PFE)’s chief executive acknowledged Tuesday that a potential merger with AstraZeneca would lead to job losses, but promised to keep key research jobs in Britain as part of its $106 billion takeover bid. Pfizer Inc. (NYSE:PFE) stock performance was 0.24% in last session and finished the day at $29.20. Traded volume was 26.29million shares in the last session and the average volume of … Continue reading Healthcare Active Stocks: Pfizer Inc. (NYSE:PFE), Merck & Co., Inc. (NYSE:MRK), Gilead Sciences (NASDAQ:GILD), MannKind Corporation (NASDAQ:MNKD)

Colin Pettis
Finance

Investor’s Alert: American International Group Inc (NYSE:AIG), General Electric Company (NYSE:GE), Petroleo Brasileiro Petrobras (NYSE:PBR), Pfizer Inc. (NYSE:PFE)

American International Group Inc (NYSE:AIG) retreated 4.1 percent after the company reported a drop in its first-quarter operating income due to rising claims costs. American International Group Inc (NYSE:AIG) stock performance was -4.14% in last session and finished the day at $50.54. Traded volume was 21.78million shares in the last session and the average volume of the stock remained 9.33million shares. The beta of the … Continue reading Investor’s Alert: American International Group Inc (NYSE:AIG), General Electric Company (NYSE:GE), Petroleo Brasileiro Petrobras (NYSE:PBR), Pfizer Inc. (NYSE:PFE)

Jason Knox
BioTech

Biotech Pre-Market Movers: Teva Pharmaceutical Industries Ltd (ADR)(NYSE:TEVA), Synergy Pharmaceuticals Inc(NASDAQ:SGYP), Pfizer Inc.(NYSE:PFE), AstraZeneca plc (ADR)(NYSE:AZN)

The American Despositary Receipts of Teva Pharmaceutical Industries Ltd (ADR)(NYSE:TEVA) edged up in recent pre-market trading on Monday after announcing over the weekend an agreement it has signed with Takeda Pharmaceutical for the marketing and sale of Rasagiline in Japan. Rasagiline is a treatment for Parkinson’s Disease developed by TEVA and has been approved in over 40 countries. TEVA closed at $48.69 on Friday in … Continue reading Biotech Pre-Market Movers: Teva Pharmaceutical Industries Ltd (ADR)(NYSE:TEVA), Synergy Pharmaceuticals Inc(NASDAQ:SGYP), Pfizer Inc.(NYSE:PFE), AstraZeneca plc (ADR)(NYSE:AZN)

Ryan Holtz
BioTech, Stock Movers

AstraZeneca plc (ADR)(NYSE:AZN) Shares Soar Pre-Market

Shares of AstraZeneca plc (ADR)(NYSE:AZN) reached a new high in pre-market trading as Pfizer Inc.(NYSE:PFE) confirmed it has attempted to renew negotiations on a possible merger. Pfizer submitted a preliminary indication of interest to the board of directors of AstraZeneca in January 2014 regarding the possible merger. AstraZeneca declined to pursue negotiations at that time, but Pfizer contacted AstraZeneca on April 26, 2014, seeking to renew … Continue reading AstraZeneca plc (ADR)(NYSE:AZN) Shares Soar Pre-Market

Chris Lewis